Incruse Ellipta Alternatives Compared
Incruse Ellipta (umeclidinium) | Symbicort (budesonide / formoterol) | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) |
|
---|
Incruse Ellipta (umeclidinium) | Symbicort (budesonide / formoterol) | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for COPD - Maintenance, COPD. Incruse Ellipta may also be used for purposes not listed in this medication guide. |
Prescription only
Symbicort is a combination inhaler that contains budesonide (a corticosteroid) and formoterol (a long-acting bronchodilator). Symbicort should only be used in people with moderate-to-severe asthma... View more |
Prescription only
Trelegy Ellipta is approved for the once-daily treatment of adults with chronic obstructive pulmonary disease (COPD) or for adults with asthma. Trelegy Ellipta is an option for the treatment of... View more |
Related suggestions |
|||||||||||||||||||||||
More about Incruse Ellipta (umeclidinium) | More about Symbicort (budesonide / formoterol) | More about Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Incruse Ellipta has an average rating of 3.6 out of 10 from a total of 34 ratings on Drugs.com. 24% of reviewers reported a positive effect, while 69% reported a negative effect. |
Symbicort has an average rating of 6.6 out of 10 from a total of 223 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 27% reported a negative effect. |
Trelegy Ellipta has an average rating of 6.9 out of 10 from a total of 254 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Incruse Ellipta prices |
View all Symbicort prices |
View all Trelegy Ellipta prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Other budesonide / formoterol brands include: Breyna |
N/A |
||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
11 hours |
7.9 hours |
24 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 102 drugs are known to interact with Incruse Ellipta:
|
A total of 825 drugs are known to interact with Symbicort:
|
A total of 530 drugs are known to interact with Trelegy Ellipta:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
April 30, 2014 |
July 21, 2006 |
September 18, 2017 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.